Bronchogen is a synthetic tetrapeptide (sequence: Ala-Glu-Asp-Leu) classified as a bioregulator. Preclinical research indicates it supports respiratory health by modulating lung inflammation, protecting the bronchial epithelium, and aiding in the regeneration of damaged pulmonary tissue. [1, 2, 3, 4]
Mechanism of Action: It is believed to interact with nuclear components to influence gene expression, promoting the restoration of ciliated cells and reducing excessive mucus-producing cells in the airway.
Research Focus: In laboratory models of Chronic Obstructive Pulmonary Disease (COPD), the peptide has been shown to reduce neutrophilic inflammation and normalize cytokine levels in bronchoalveolar fluid.
Usage Status: Bronchogen is strictly designated for research and laboratory purposes only and is not approved for human consumption or as a medical treatment
